Journals / Turkish Journal of Medical Sciences / 2008 / Cilt: 38 - Sayı: 3

Is MEFVGene Arg202Gln (605 G>A) A Disease-Causing Mutation?

Pages
205–208
Publication Date
2008-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, R202Q might be a disease-causing mutation at least in some of the FMF patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Familial Mediterranean fever (FMF) is an autosomal recessive disease.
📊
Key Findings & Data:Arg202Gln was reported as a frequent polymorphism, and G allele of the mutation was in linkage disequilibrium with M694V.
💡
Conclusion & Impact:Thus, R202Q might be a disease-causing mutation at least in some of the FMF patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Familial Mediterranean fever (FMF) · amyloidosis · MEFVgene

Abstract

Aim: Familial Mediterranean fever (FMF) is an autosomal recessive disease. Arg202Gln was reported as a frequent polymorphism, and G allele of the mutation was in linkage disequilibrium with M694V. Thus, the aim of this study was to determine the distribution of the R202Q (605G>A) mutation in exon 2 of the MEFVgene in Turkish FMF patients and controls. Materials and Methods: The study included 160 FMF and 41 FMF/amyloid patients and 121 controls. Sequencing of exon 10 and exon 5 and PCR/RFLP analysis of E148Q and R202Q mutations of exon 2 of the MEFVgene were performed for all patients according to previously described techniques. Results: We found that 5 out of 76 M694V homozygote FMF patients carry a different haplotype from the one expected. Eleven of the patients had homozygous GG allele indicating the second haplotype. None of the 121 controls was homozygous for R202Q (605G>A), but 8 controls were heterozygous for M694V mutation and 5 (4.1%) of them were in linkage disequilibrium with R202Q. Conclusions: It seems that R202Q has no effect when it is in heterozygous state; however, when combined with another disease-causing mutation, the clinical spectrum appears. Thus, R202Q might be a disease-causing mutation at least in some of the FMF patients.

Özet

Aim: Familial Mediterranean fever (FMF) is an autosomal recessive disease. Arg202Gln was reported as a frequent polymorphism, and G allele of the mutation was in linkage disequilibrium with M694V. Thus, the aim of this study was to determine the distribution of the R202Q (605G>A) mutation in exon 2 of the MEFVgene in Turkish FMF patients and controls. Materials and Methods: The study included 160 FMF and 41 FMF/amyloid patients and 121 controls. Sequencing of exon 10 and exon 5 and PCR/RFLP analysis of E148Q and R202Q mutations of exon 2 of the MEFVgene were performed for all patients according to previously described techniques. Results: We found that 5 out of 76 M694V homozygote FMF patients carry a different haplotype from the one expected. Eleven of the patients had homozygous GG allele indicating the second haplotype. None of the 121 controls was homozygous for R202Q (605G>A), but 8 controls were heterozygous for M694V mutation and 5 (4.1%) of them were in linkage disequilibrium with R202Q. Conclusions: It seems that R202Q has no effect when it is in heterozygous state; however, when combined with another disease-causing mutation, the clinical spectrum appears. Thus, R202Q might be a disease-causing mutation at least in some of the FMF patients.

🔖

Cite This Article

ÖZTÜRK, A., ÖZÇAKAR, B., EKİM, M., AKAR, N. (2008). Is MEFVGene Arg202Gln (605 G>A) A Disease-Causing Mutation?. Turkish Journal of Medical Sciences, Cilt: 38 - Sayı: 3, 205–208. https://ajindex.com/articles/723638

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet 2006; 367(9515): 1016-24
  2. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314(16): 1001-5
  3. Turkish FMF study group. Familial Mediterranean fever in Turkey: results of a nationwide study. Medicine 2005; 84: 1-11
  4. Centola M, Aksentijevich.I, Kastner DL. The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 1998; 7: 1581-8. 5.
  5. Livneh A, Langevita P, Zemer D, Zaks N, Kees S, Lidar T et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-85
  6. Akar N, Akar E, Özel D, Tekin M, Ekim M, Yalç›nkaya F. A note on mutation analysis in familial Mediterranean fever. Pediatr Nephrol 2003; 18: 196-7
  7. Akar N, Misirlioglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 2000; 15: 118-9
  8. Y›lmaz E, Ozen S, Balc› B, Duzova A, Topaloglu R, Besbas N et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9(7): 553-5
  9. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25–31
  10. International FMF Consortium. Ancient missense mutations in a new member of the Roret gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797–807
  11. Ben-Cherit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis-phenotype genotype correlation, treatment and prognosis. J Nephrol 2003; 16(3): 431-4
  12. Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473–83
  13. Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S et al. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 2007; 71(5): 458-67.